Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey

被引:31
作者
Yamakawa-Kobayashi, K [1 ]
Yanagi, H
Fukayama, H
Hirano, C
Shimakura, Y
Yamamoto, N
Arinami, T
Tsuchiya, S
Hamaguchi, H
机构
[1] Univ Tsukuba, Inst Basic Med Sci, Dept Med Genet, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Inst Community Med, Tsukuba, Ibaraki 3058575, Japan
[3] Univ Tsukuba, Inst Clin Med, Tsukuba, Ibaraki 3058575, Japan
关键词
D O I
10.1093/hmg/8.2.331
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To determine the frequency of familial hypoalphalipoproteinemia in the general population due to mutation of the apolipoprotein A-I (apo A-I) gene, we analyzed sequence variations in the apo A-I gene. The subjects were 67 children with a low high-density lipoprotein (HDL) cholesterol level (less than or equal to 38 mg/dl, below the fifth percentile in the population of this study) who were screened from 1254 schoolchildren through a school survey, Four different mutations with deleterious potential, three frameshifts and one splice site mutation, were identified in four of the subjects. The plasma apo A-I levels of the four children with apo A-I gene mutations were reduced to approximately half of the normal levels and were below the first percentile of the general population distribution (80 mg/dl), Thus, the frequency of hypoalphalipoproteinemia due to a mutant apolipoprotein A-I gene was estimated at 6% (95% CI: 2.4-14.4%) in the subjects with low HDL cholesterol levels and 0.3% (95% CI: 0.1-0.8%) in the Japanese population. This suggests that familial hypoalphalipoproteinemia due to apo A-I gene mutations is relatively common.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 46 条
[1]  
ALLAN CM, 1992, J BIOL CHEM, V267, P13257
[2]   RELATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES TO INCIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE (THE PROCAM EXPERIENCE) [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (07) :733-737
[3]  
ASSMANN G, 1993, CIRCULATION, V87, P28
[4]  
AVOGARO P, 1979, LANCET, V1, P901
[5]   High density lipoproteins and coronary heart disease [J].
Barter, PJ ;
Rye, KA .
ATHEROSCLEROSIS, 1996, 121 (01) :1-12
[6]  
BRESLOW JL, 1995, METABOLIC MOL BASES, V2, P2031
[7]   The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-I-Milano [J].
Bruckert, E ;
vonEckardstein, A ;
Funke, H ;
Beucler, I ;
Wiebusch, H ;
Turpin, G ;
Assmann, G .
ATHEROSCLEROSIS, 1997, 128 (01) :121-128
[8]   High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein [J].
Calabresi, L ;
Franceschini, G .
CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (04) :219-224
[9]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[10]  
FIELDING CJ, 1995, J LIPID RES, V36, P211